Themis Medicare Quarterly Results for Trading Insights
THEMISMED • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹-4 Cr
QSept 2025
Themis Medicare Quarterly Results Key Highlights
- Revenue of ₹83 Cr in Sept 2025 (+13.7% vs Mar 2025, -32.5% vs Sept 2024)
- Net Profit of ₹-4 Cr in Sept 2025 (+60.0% vs Mar 2025, -128.6% vs Sept 2024)
- EBITDA of ₹2 Cr in Sept 2025 (+133.3% vs Mar 2025)
- Operating Margin of -4.0% in Sept 2025 (+7.0pp vs Mar 2025)
- Earnings Per Share of ₹-0.39 in Sept 2025 (+62.9% vs Mar 2025)
Themis Medicare Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 83 | 73 | 99 | 123 | 103 | 13.7% | -32.5% |
| Net Profit (₹ Cr) | -4 | -10 | -14 | 14 | 7 | - | - |
| EBITDA (₹ Cr) | 2 | -6 | -9 | 23 | 14 | - | - |
| EPS (₹) | -0.39 | -1.05 | -1.54 | 1.55 | 0.72 | - | - |
| Operating Margin (%) | -4.0% | -11.0% | -10.0% | 15.0% | 10.0% | - | - |
Themis Medicare Share Price Trend Around Quarterly Results
Visualize Themis Medicare's 1-year price movement across quarterly results — ideal for logging trades in Themis Medicare share price
chart using Tickjournal. All values in ₹.
Related Pages for Themis Medicare
Additional stock information and data for THEMISMED
Revenue Trend (₹ Cr)
Sept 2024
123
Jun 2025
99
Mar 2025
73
Sept 2025
83
Net Profit Trend (₹ Cr)
Sept 2024
14
Jun 2025
-14
Mar 2025
-10
Sept 2025
-4
Operating Margin Trend (%)
Sept 2024
15.0%
Jun 2025
-10.0%
Mar 2025
-11.0%
Sept 2025
-4.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Themis Medicare quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹417,052.40 Cr | 1729.9 | 14,875 | 3,125 | +10.8% | - | 21.0% | 133.1 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6616.5 | 2,860 | 689 | +7.1% | - | 24.1% | 254.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3963.4 | 3,219 | 591 | +11.3% | - | 18.4% | 226.0 |
|
Cipla
Sept 2025 |
₹118,572.82 Cr | 1465.7 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.6 |
|
Dr Reddys Laborator…
Sept 2025 |
₹100,998.62 Cr | 1210.1 | 9,135 | 1,337 | +1.1% | - | 14.6% | 74.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores